Prostate Cancer: New Insights for the Healthcare Professional: 2011 Edition
ScholarlyEditions, Jan 9, 2012 - Medical - 778 pages
Prostate Cancer: New Insights for the Healthcare Professional: 2011 Edition is a ScholarlyEditions™ eBook that delivers timely, authoritative, and comprehensive information about Prostate Cancer.
The editors have built Prostate Cancer: New Insights for the Healthcare Professional: 2011 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about Prostate Cancer in this eBook to be deeper than what you can access anywhere else, as well as consistently reliable, authoritative, informed, and relevant. The content of Prostate Cancer: New Insights for the Healthcare Professional: 2011 Edition has been produced by the world’s leading scientists, engineers, analysts, research institutions, and companies. All of the content is from peer-reviewed sources, and all of it is written, assembled, and edited by the editors at ScholarlyEditions™ and available exclusively from us. You now have a source you can cite with authority, confidence, and credibility.
What people are saying - Write a review
Genomewide linkage analyses of hereditary prostate cancer families with colon cancer provide further evidence for a susceptibility locus on 15q11q14
Vitamin D pathway gene variants and prostate cancer prognosis
Heat shock protein 27 confers resistance to androgen ablation and chemotherapy in prostate cancer cells through eIF4E
Slug inhibits proliferation of human prostate cancer cells via downregulation of cyclin D1 expression
New prostate cancer therapy data have been reported by A Hille and coauthors
New prostatespecific antigen study findings recently were published by N Larranaga and coresearchers
Serum prostatespecific antigen levels reflect the androgen milieu in patients with localized prostate cancer receiving androgen deprivation therapy Tu...
Role of monocytelineage cells in prostate cancer cell invasion and tissue factor expression
18Ffluorocholine positronemissioncomputed tomography for lymph node staging of patients with prostate cancer preliminary results of a prospectiv...
Expression of tolllike receptor9 is increased in poorly differentiated prostate tumors
Effect of lycopene on androgen receptor and prostatespecific antigen velocity
Macrophage migration inhibitory factor is a direct target of HBP1mediated transcriptional repression that is overexpressed in prostate cancer
Consolidation of the cancer genome into domains of repressive chromatin by longrange epigenetic silencing LRES reduces transcriptional plasticity
Prediction of a gene regulatory network linked to prostate cancer from gene expression microRNA and clinical data
Identification of organoselenium compounds that possess chemopreventive properties in human prostate cancer LNCaP cells
A novel type of cellular senescence that can be enhanced in mouse models and human tumor xenografts to suppress prostate tumorigenesis
Engineering of selfassembled nanoparticle platform for precisely controlled combination drug therapy
Phosphoinositide 3kinase pathway activation in phosphate and tensin homolog PTENdeficient prostate cancer cells is independent of receptor tyrosin...
Inherited variations in AR ESR1 and ESR2 genes are not associated with prostate cancer aggressiveness or with efficacy of androgen deprivation ther...
Prostate Cancer Risk Allele Specific for African Descent Associates with Pathologic Stage at Prostatectomy
Changes in cortical cytoskeletal and extracellular matrix gene expression in prostate cancer are related to oncogenic ERG deregulation
p53dependent induction of prostate cancer cell senescence by the PIM1 protein kinase
Identification of differentially methylated genes in normal prostate tissues from African American and Caucasian men
The role of PI 3kinase p110beta in AKT signally cell survival and proliferation in human prostate cancer cells
Wnt11 promotes neuroendocrinelike differentiation survival and migration of prostate cancer cells
Polymorphisms in inflammatory genes plasma antioxidants and prostate cancer risk
Mutation analysis of the MSMB gene in familial prostate cancer
NBBS isolated from Pygeum africanum bark exhibits androgen antagonistic activity inhibits AR nuclear translocation and prostate cancer cell growth
Effect of mtDNA mutation on tumor malignant degree in patients with prostate cancer
Is prostate cancer prevention with selenium all in the genes?
Nuclear roundness variance predicts prostate cancer progression metastasis and death A prospective evaluation with up to 25 years of followup after r...
Androgeninduced TOP2Bmediated doublestrand breaks and prostate cancer gene rearrangements
Bypass mechanisms of the androgen receptor pathway in therapyresistant prostate cancer cell models
Systematic structurefunction analysis of androgen receptor Leu701 mutants explains the properties of the prostate cancer mutant L701H
Apoptosis regulators Fau and BclG are downregulated in prostate cancer
Analysis of gene expression in prostate cancer epithelial and interstitial stromal cells using laser capture microdissection
The antiandrogen bicalutamide activates the androgen receptor AR with a mutation in codon 741 through the mitogen activated protein kinase MAR...
Antiandrogen withdrawal syndrome and alternative antiandrogen therapy associated with the W741C mutant androgen receptor in a novel prostate c...
Human heterochromatin protein 1 isoform HP1beta enhances androgen receptor activity and is implicated in prostate cancer growth
Peroxisome proliferatoractivated receptor gamma coactivator1alpha interacts with the androgen receptor AR and promotes prostate cancer cell growt...
Polymorphisms in the AR and PSA genes as markers of susceptibility and aggressiveness in prostate cancer
Androgen receptor signaling and mutations in prostate cancer
Cadherin11 increases migration and invasion of prostate cancer cells and enhances their interaction with osteoblasts
Effects of the 5 alphareductase inhibitor dutasteride on gene expression in prostate cancer xenografts
Gene networks and microRNAs implicated in aggressive prostate cancer
Recent advances in understanding hormonal therapy resistant prostate cancer
Teucrium polium plant extract inhibits cell invasion and motility of human prostate cancer cells via the restoration of the Ecadherincatenin complex
Germline BRCA mutations denote a clinicopathologic subset of prostate cancer
Integrative genomic profiling of human prostate cancer
Localization of Candidate Genes in a Region of High Frequency of Microvariant Alleles for Prostate Cancer Susceptibility The Chromosome Region ...
Systemic delivery of synthetic microRNA16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cellcycle genes
Genomic profiling of tumor initiating prostatospheres
Inhibition of xenotropic murine leukemia virusrelated virus by APOBEC3 proteins and antiviral drugs
Androgen receptor sequence and variations in several common prostate cancer cell lines
Dehydroepiandrosterone administration or Galphaq overexpression induces betacateninTCell factor signaling and growth via increasing association o...
Familybased association analysis of 42 hereditary prostate cancer families identifies the Apolipoprotein L3 region on chromosome 22q12 as a risk lo...
Refining the prostate cancer genetic association within the JAZF1 gene on chromosome 7p152
New findings in prostate cancer described by N Rabiau and coresearchers
New prostate cancer research from University Hospital Comprehensive Cancer Center outlined
New prostate cancer study results reported from Institute of Cancer Research
Tumor suppressor function of androgen receptor coactivator ARA70alpha in prostate cancer
Gene polymorphisms and prostate cancer the evidence
Targeting alternative splicing in prostate oncology
Trilostane an inhibitor of 3223hydroxysteroid dehydrogenase has an agonistic activity on androgen receptor in human prostate cancer cells
Tomatobased food products for prostate cancer prevention what have we learned?
REICDkk3 stable transfection reduces the malignant phenotype of mouse prostate cancer RM9 cells
Diastereomers of the brominated flame retardant 12dibromo412 dibromoethylcyclohexane induce androgen receptor activation in the hepg2 hepatoc...
Urine markers in monitoring for prostate cancer
Methylated genes as potential biomarkers in prostate cancer
The rs1447295 and DG8S737 markers on chromosome 8q24 and cancer risk in the Polish population
Detailed analysis of expression and promoter methylation status of apoptosisrelated genes in prostate cancer
Distinct genomic alterations in prostate cancers in Chinese and Western populations suggest alternative pathways of prostate carcinogenesis
The identification of chromosomal translocation t46q22q15 in prostate cancer
Differential expression of PCA3 and its overlapping PRUNE2 transcript in prostate cancer
Reports outline secreted matrix metalloproteinases research from R Gil Ugarteburu and colleagues
Research from Cleveland Clinic in the area of prostate cancer published
Research from R Benelli et al broadens understanding of prostate cancer
Research on prostate cancer published by scientists at INSERM
Research on prostate cancer reported by scientists at University Hospital Department of Urology
Microvesicle Induction of Prostate Specific Gene Expression in Normal Human Bone Marrow Cells
Mild folate deficiency induces genetic and epigenetic instability and phenotype changes in prostate cancer cells
Prx1 enhances androgen receptor function in prostate cancer cells by increasing receptor affinity to dihydrotestosterone
Survival advantage of AMPK activation to androgenindependent prostate cancer cells during energy stress
Replacement of imidazolyl by pyridyl in biphenylmethylenes results in selective CYP17 and dual CYP17CYP11B1 inhibitors for the treatment of pro...
Polymorphisms in estrogen related genes may modify the protective effect of isoflavones against prostate cancer risk in Japanese men
Downregulation of nucleostemin causes G1 cell cycle arrest via a p53independent pathway in prostate cancer PC3 cells
MicroRNA145 targets BNIP3 and suppresses prostate cancer progression
Association of TMPRSS2 and KLK11 gene expression levels with clinical progression of human prostate cancer
MnSOD Val16Ala polymorphism and prostate cancer susceptibility a metaanalysis involving 8962 subjects
Simultaneous inactivation of Par4 and PTEN in vivo leads to synergistic NFkappaB activation and invasive prostate carcinoma
Genomic Analysis Highlights the Role of the JAKSTAT Signaling in the Antiproliferative Effects of Dietary FlavonoidAshwagandha in Prostate Canc...
Studies in the area of genetics and prostate cancer reported from Cleveland Clinic
Studies in the area of prostate cancer reported from E Comperat and coresearchers
Study findings from Oncology Institute of Southern Switzerland broaden understanding of transcription factors
Study results from HC Whitaker and colleagues broaden understanding of prostate cancer
Study results from University Medical Center in the area of prostate cancer published
Detection of TMPRSS2ETS fusions by a multiprobe fluorescence in situ hybridization assay for the early diagnosis of prostate cancer a pilot study
Antiproliferative mechanisms of the flavonoids 22dihydroxychalcone and fisetin in human prostate cancer cells
The 4q27 locus and prostate cancer risk
Association of SPINK1 expression and TMPRSS2ERG fusion with prognosis in endocrinetreated prostate cancer
Correlation of centrosomal aberrations with cell differentiation and DNA ploidy in prostate cancer
Expression of two testisspecific genes SPATA19 and LEMD1 in prostate cancer
Progression to metastatic stage in a cellular model of prostate cancer is associated with methylation of the androgen receptor gene and transcriptional ...
Transcription factor E2F1 is a potent transactivator of the insulinlike growth factorI receptor IGFIR gene
Polymorphisms of TP53 codon 72 with prostate carcinoma risk a metaanalysis
Activating mutation V617F in the tyrosine kinase JAK2 is absent in locallyconfined or castrationresistant prostate cancer
Cyclin D1 splice variants polymorphism risk and isoformspecific regulation in prostate cancer
Stat5 promotes metastatic behavior of human prostate cancer cells in vitro and in vivo
Aberrant activation of the androgen receptor by NFkappaB2p52 in prostate cancer cells
Validation of a quantitative flow cytometer assay for monitoring HER2neu expression level in cellbased cancer immunotherapy products
PCRfree method detects high frequency of genomic instability in prostate cancer
Establishment and characterization of a pair of nonmalignant and malignant tumor derived cell lines from an African American prostate cancer patient
Novel methods to identify biologically relevant genes for leukemia and prostate cancer from gene expression profiles
Coumaphos exposure and incident cancer among male participants in the Agricultural Health Study AHS
A novel role for WntCa2+ signaling in actin cytoskeleton remodeling and cell motility in prostate cancer
Improved prediction of biochemical recurrence after radical prostatectomy by genetic polymorphisms
Suitable reference genes for relative quantification of miRNA expression in prostate cancer
Identification of viral infections in the prostate and evaluation of their association with cancer
From gene to clinic TMAbased clinical validation of molecular markers in prostate cancer
Osteolytic prostate cancer cells induce the expression of specific cytokines in boneforming osteoblasts through a Stat35dependent mechanism
Therapeutic Potential of Adult Bone MarrowDerived Mesenchymal Stem Cells in Prostate Cancer Bone Metastasis
Associations between an obesity related genetic variant FTO rs9939609 and prostate cancer risk
Relaxin drives Wnt signaling through upregulation of PCDHY in prostate cancer
A role for the clock gene per1 in prostate cancer
Genomewide analysis of androgen receptor binding and gene regulation in two CWR22derived prostate cancer cell lines
Green tea polyphenols and metabolites in prostatectomy tissue implications for cancer prevention
Polycomb group protein enhancer of zeste 2 is an oncogene that promotes the neoplastic transformation of a benign prostatic epithelial cell line
Long term increased expression of the short form 1b prolactin receptor in PC3 human prostate cancer cells decreases cell growth and migration and c...
A group of genomebased biomarkers that add to a Kattan nomogram for predicting progression in men with highrisk prostate cancer
Expression of SPANX proteins in normal prostatic tissue and in prostate cancer
Proapoptotic activity of ergosterol peroxide and 22Eergosta722dien5alphahydroxy36dione in human prostate cancer cells
8q24 allelic imbalance and MYC gene copy number in primary prostate cancer
Methylation of a single intronic CpG mediates expression silencing of the PMP24 gene in prostate cancer
The molecular mechanism of Vav3 oncogene on upregulation of androgen receptor activity in prostate cancer cells
Alterations in LMTK2 MSMB and HNF1B gene expression are associated with the development of prostate cancer
Comparison of gene expression in LNCaP prostate cancer cells after treatment with bicalutamide or 5alphareductase inhibitors
Primary prostate cancer cultures are models for androgenindependent transit amplifying cells
FZD4 as a Mediator of ERG OncogeneInduced WNT Signaling and EpithelialtoMesenchymal Transition in Human Prostate Cancer Cells
Elevated expression of Ki67 identifies aggressive prostate cancers but does not distinguish BRCA1 or BRCA2 mutation carriers
8q24 sequence variants in relation to prostate cancer risk among men of African descent a casecontrol study
A FOXA1binding enhancer regulates Hoxb13 expression in the prostate gland
The migration and invasion of human prostate cancer cell lines involves CD151 expression
Induced chromosomal proximity and gene fusions in prostate cancer
Somatic single hits inactivate the Xlinked tumor suppressor FOXP3 in the prostate
Topological significance analysis of gene expression and proteomic profiles from prostate cancer cells reveals key mechanisms of androgen response
Comprehensive analysis of the cytokinerich chromosome 5q311 region suggests a role for IL4 gene variants in prostate cancer risk
PI3KAKTmTOR pathway is dominant over androgen receptor signaling in prostate cancer cells
Expression of the actinassociated protein transgelin SM22 is decreased in prostate cancer
Contextdependent effects of genomewide association study genotypes and macroenvironment on time to biochemical prostate specific antigen failure...
Epigallocatechin3gallate induces Du145 prostate cancer cell death via downregulation of inhibitor of DNA binding 2 a dominant negative helixloop...
Integrin alpha 7 interacts with high temperature requirement A2 HtrA2 to induce prostate cancer cell death
The microRNA profile of prostate carcinoma obtained by deep sequencing
Targeted knockdown of EGR1 inhibits IL8 production and IL8mediated invasion of prostate cancer cells through suppressing EGR1NFkappaB syner...
Gene expression profiles in the PC3 human prostate cancer cells induced by NKX31
Validation of suitable endogenous control genes for expression studies of miRNA in prostate cancer tissues
Vitamin D and prostate cancer the role of membrane initiated signaling pathways in prostate cancer progression
The relationship between proangiogenic gene expression levels in prostate cancer and their prognostic value for clinical outcomes
Runx2 transcriptome of prostate cancer cells insights into invasiveness and bone metastasis
Identification of novel truncated androgen receptor AR mutants including unreported premRNA splicing variants in the 22Rv1 hormonerefractory pr...
miR193b is an epigenetically regulated putative tumor suppressor in prostate cancer
Genetic alterations and changes in expression of histone demethylases in prostate cancer
Characterization of the Phosphoproteome in LNCaP Prostate Cancer Cells by InGel Isoelectric Focusing and Tandem Mass Spectrometry
Downregulation of human DAB2IP gene expression in prostate cancer cells results in resistance to ionizing radiation
Role of DAB2IP in modulating epithelialtomesenchymal transition and prostate cancer metastasis
5alphaDHDOC 5alphadihydrodeoxycorticosterone activates androgen receptor in castrationresistant prostate cancer
Genomewide linkage analysis of 1233 prostate cancer pedigrees from the International Consortium for Prostate Cancer Genetics using novel sumLIN...
Zoledronic acid decreases mRNA sixtransmembrane epithelial antigen of prostate protein expression in prostate cancer cells
FKBP51 promotes assembly of the Hsp90 chaperone complex and regulates androgen receptor signaling in prostate cancer cells
A novel class of small RNAs tRNAderived RNA fragments tRFs
CYP17 polymorphisms and prostate cancer outcomes
Comparative analyses of chromosome alterations in softtissue metastases within and across patients with castrationresistant prostate cancer
PopulationBased Study of the Association of Variants in Mismatch Repair Genes with Prostate Cancer Risk and Outcomes
The expression of osteoclastogenesisassociated factors and osteoblast response to osteolytic prostate cancer cells
The senescence pathway in prostatic carcinogenesis
Melatonin resynchronizes dysregulated circadian rhythm circuitry in human prostate cancer cells
Pim1 promotes human prostate cancer cell tumorigenicity and cMYC transcriptional activity
Androgen receptor interacts with telomeric proteins in prostate cancer cells
Association of 17 prostate cancer susceptibility loci with prostate cancer risk in Chinese men
Estimation of absolute risk for prostate cancer using genetic markers and family history
Inherited genetic variant predisposes to aggressive but not indolent prostate cancer
MicroRNA101 negatively regulates Ezh2 and its expression is modulated by androgen receptor and HIF1alphaHIF1beta
Prostate cancer riskassociated variants reported from genomewide association studies metaanalysis and their contribution to genetic Variation
Downregulation of Notch1 and Jagged1 inhibits prostate cancer cell growth migration and invasion and induces apoptosis via inactivation of Akt mT...
Results from a prostate cancer admixture mapping study in AfricanAmerican men
Transcriptional regulation of Rex1 zfp42 in normal prostate epithelial cells and prostate cancer cells
Testing the circadian gene hypothesis in prostate cancer a populationbased casecontrol study
Salvage radiotherapy for rising prostatespecific antigen levels after radical prostatectomy for prostate cancer doseresponse analysis
Reduced tumor necrosis factor receptorassociated death domain expression is associated with prostate cancer progression
An AntiUrokinase Plasminogen Activator Receptor Antibody ATN658 Blocks Prostate Cancer Invasion Migration Growth and Experimental Skeletal...
Value of realtime elastography targeted biopsy for prostate cancer detection in men with prostate specific antigen 125 ngml or greater and 400 ngml ...
Antiepidermal growth factor receptor monoclonal antibody cetuximab plus Doxorubicin in the treatment of metastatic castrationresistant prostate can...
Polymorphisms at the Microseminoproteinbeta locus associated with physiologic variation in betamicroseminoprotein and prostatespecific antigen lev...
Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer casecontrol study
Normalization of prostate specific antigen in patients treated with intensity modulated radiotherapy for clinically localized prostate cancer
Trends of the primary therapy for patients with prostate cancer in Nara urooncological research group NUORG a comparison between the CaPSURE ...
New findings from M Giesing and coauthors describe advances in kallikreins
New prostate cancer study findings recently were reported by researchers at Royal Marsden Hospital
Inhibition of constitutive and cxcchemokineinduced NFkappaB activity potentiates ansamycinbased HSP90inhibitor cytotoxicity in castrateresistant p...
Report summarizes prostate cancer study findings from University Hospital
Reports on prostate cancer findings from C Hartel and coresearchers provide new insights
Research results from TG Urbano and colleagues update understanding of prostate cancer
Vitamin D deficiency and insufficiency among patients with prostate cancer
Prostatespecific antigen kinetics following externalbeam radiotherapy and temporary Ir192 or permanent I125 brachytherapy for prostate cancer
Androgen receptor survival signaling is blocked by antibeta2microglobulin monoclonal antibody via a MAPKlipogenic pathway in human prostate c...
Tolllike receptor 3 regulates angiogenesis and apoptosis in prostate cancer cell lines through hypoxiainducible factor 1 alpha
Prostate specific antigen mass ratio potential as a prostate cancer screening tool
Prognostic significance of undetectable ultrasensitive prostatespecific antigen nadir after radical prostatectomy
Zoledronate stimulates gamma delta T cells in prostate cancer patients
Freedom from a detectable ultrasensitive prostatespecific antigen at two years after radical prostatectomy predicts a favorable clinical outcome analysi...
Integrin involvement in freeze resistance of androgeninsensitive prostate cancer
Studies from LF Arenas et al in the area of prostate cancer described
Detection rates of nonpalpable prostate cancer in Korean men with prostatespecific antigen levels between 25 and 40 ngmL
Impacts of antiEGFR monoclonal antibody in prostate cancer PC3 cells
Combined inhibitory effects of soy isoflavones and curcumin on the production of prostatespecific antigen
The chromatin remodeling factor SRCAP modulates expression of prostate specific antigen and cellular proliferation in prostate cancer cells
Tolllike receptor 9 agonists upregulates the expression of cyclooxygenase2 via activation of NFkappaB in prostate cancer cells
Highresolution animal PET imaging of prostate cancer xenografts with three different 64Culabeled antibodies against native celladherent PSMA
Intraoperative radiotherapy during radical prostatectomy for locally advanced prostate cancer technical and dosimetric aspects
Prostatespecific antigen relapsefree survival and sideeffects in 734 patients with up to 10 years of followup with localized prostate cancer treated by p...
Suicide risk in men with prostatespecific antigendetected early prostate cancer a nationwide populationbased cohort study from PCBaSe Sweden
Metastatic prostate cancer in an asymptomatic patient with an initial prostatespecific antigen PSA serum concentration of 21380 ngml
BRCA1 loss preexisting in small subpopulations of prostate cancer is associated with advanced disease and metastatic spread to lymph nodes and peri...
Performance of the prostate cancer antigen 3 PCA3 gene and prostatespecific antigen in prescreened men exploring the value of PCA3 for a firstline ...
Oral selenium supplementation has no effect on prostatespecific antigen velocity in men undergoing active surveillance for localized prostate cancer
Immune rejection in a humanized model of murine prostate cancer
Tolllike receptor 3mediated suppression of TRAMP prostate cancer shows the critical role of type I interferons in tumor immune surveillance
Targeting prostate cancer cells in vivo using a rapidly internalizing novel human singlechain antibody fragment
The Ron receptor tyrosine kinase positively regulates angiogenic chemokine production in prostate cancer cells
Systemic inflammatory response and survival in patients with localised prostate cancer 10year followup
Regulation of Erk12 activation by osteopontin in PC3 human prostate cancer cells
CC chemokine ligand 2 CCL2 promotes prostate cancer tumorigenesis and metastasis
Decreasing Rate and Extent of Lymph Node Staging in Patients Undergoing Radical Prostatectomy May Undermine the Rate of Diagnosis of Lymph ...
Use of a combination of biomarkers in serum and urine to improve detection of prostate cancer
Overexpression of macrophage inhibitory cytokine1 induces metastasis of human prostate cancer cells through the FAKRhoA signaling pathway
Telomere DNA content in prostate biopsies predicts early rise in prostatespecific antigen after radical prostatectomy for prostate cancer
Multiple roles of chemokine CC motif ligand 2 in promoting prostate cancer growth
Association between integrin expression and prognosis in localized prostate cancer
Effects of antiEGFR antibody cetuximab on androgenindependent prostate cancer cells
Prostate cancer death of men treated with initial active surveillance clinical and biochemical characteristics
Anibamine a natural product CCR5 antagonist as a novel lead for the development of antiprostate cancer agents
Bacillus CalmetteGuerin cellwall skeleton enhances the killing activity of cytotoxic lymphocyteactivated human dendritic cells transduced with the pr...
Differential expression of the alpha2 chain of the interleukin13 receptor in metastatic human prostate cancer ARCaPM cells
A remote arenebinding site on prostate specific membrane antigen revealed by antibodyrecruiting small molecules
Chemical control over immune recognition a class of antibodyrecruiting small molecules that target prostate cancer
Risk and Prevention
The dietary isothiocyanate sulforaphane modulates gene expression and alternative gene splicing in a PTEN null preclinical murine model of prostate...
Prostate cancer risk in relation to insulinlike growth factor IGFI and IGFbinding protein3 A nested casecontrol study in large scale cohort study in Ja...
Efficacy of antioxidant vitamins and selenium supplement in prostate cancer prevention a metaanalysis of randomized controlled trials
Metabolic sequelae associated with androgen deprivation therapy for prostate cancer
The effect of warfarin use on clinical stage and histological grade of prostate cancer
Use of nonsteroidal antiinflammatory drugs and prostate cancer risk a metaanalysis
The relationship between prostatespecific antigen and prostate cancer risk the Prostate Biopsy Collaborative Group
Coffee consumption and risk of prostate cancer a metaanalysis of epidemiological studies
Plasma organochlorines and subsequent risk of prostate cancer in Japanese men a nested casecontrol study
Plasma testosterone and sex hormonebinding globulin concentrations and the risk of prostate cancer among Japanese men a nested casecontrol study
Comprehensive resequence analysis of a 97 kb region of chromosome 10q112 containing the MSMB gene associated with prostate cancer
A comprehensive resequence analysis of the KLK15KLK3KLK2 locus on chromosome 19q1333
Cadmium burden and the risk and phenotype of prostate cancer
New prostate cancer risk factors research from University of Barcelona Department of Urology discussed
Prostate cancer chemopreventive activity of phenethyl isothiocyanate through epigenetic regulation review
Erythrocyte fatty acids and prostate cancer risk a comparison of methods
Active surveillance for lowrisk prostate cancer
The presence of prostate cancer on saturation biopsy can be accurately predicted
Research from G Chodick and coresearchers in the area of diabetes published
Research from INSERM yields new findings on prostate cancer
Influence of IGFBP3 gene polymorphisms on IGFBP3 serum levels and the risk of prostate cancer in lowrisk Korean men
Relationship between three polymorphisms of methylenetetrahydrofolate reductase MTHFR C677T A1298C and G1793A gene and risk of prostate c...
Association of genetic polymorphisms in the interleukin10 promoter with risk of prostate cancer in Chinese
Finasteride treatment alters MMP2 and 9 gene expression and activity in the rat ventral prostate
Tumor progression in the LPBTag transgenic model of prostate cancer is altered by vitamin D receptor and serum testosterone status
Studies from Fox Chase Cancer Center Department of Surgical Oncology in the area of prostate cancer prevention published
Studies from RS Kirby et al add new findings in the area of prostate cancer prevention
Study results from L Klotz and colleagues broaden understanding of prostate cancer
Phytanic acidan overlooked bioactive fatty acid in dairy fat?
Fruits and vegetables in relation to prostate cancer in Japanese men the Japan Public Health CenterBased Prospective Study
Welldone meat consumption NAT1 and NAT2 acetylator genotypes and prostate cancer risk the multiethnic cohort study
Associations of sexual dysfunction symptoms with PSAdetected localised and advanced prostate cancer A casecontrol study nested within the UK pop...
Blood pressure and risk of prostate cancer Cohort Norway CONOR
Circulating folate vitamin B12 homocysteine vitamin B12 transport proteins and risk of prostate cancer a casecontrol study systematic review and met...
Socioeconomic status and prostate cancer incidence and mortality rates among the diverse population of California
Statin use and risk of prostate cancer recurrence in men treated with radiation therapy
CYP 1A1 polymorphism and organochlorine pesticides levels in the etiology of prostate cancer
The potential efficacy of 33diindolylmethane in prevention of prostate cancer development
Association of selenium tocopherols carotenoids retinol and 15isoprostane F2t in serum or urine with prostate cancer risk the multiethnic cohort
Interaction among variant vascular endothelial growth factor VEGF and its receptor in relation to prostate cancer risk
Plasma phytanic acid concentration and risk of prostate cancer results from the European Prospective Investigation into Cancer and Nutrition
VEGF and prostatic cancer a systematic review
Body size and risk of prostate cancer in Jamaican men
Array CGH as a potential predictor of radiocurability in intermediate risk prostate cancer
Diet and prostate cancer mechanisms of action and implications for chemoprevention
Review Green tea polyphenols in chemoprevention of prostate cancer preclinical and clinical studies
The metabolic syndrome and the risk of prostate cancer under competing risks of death from other causes
Costeffectiveness of prostate cancer chemoprevention among highrisk men
Comparison of two methods for estimating absolute risk of prostate cancer based on single nucleotide polymorphisms and family history
Prostate cancer in AfricanAmerican men and polymorphism in the calciumsensing receptor
Therapies and Treatments
Kindlin2 controls sensitivity of prostate cancer cells to cisplatininduced cell death
Combination chemotherapy with weekly paclitaxel or docetaxel carboplatin and estramustine for hormonerefractory prostate cancer
Suppressed tumour growth and enhanced chemosensitivity by RNA interference targeting AuroraA in the PC3 human prostate cancer model
KG135 enriched with selected ginsenosides inhibits the proliferation of human prostate cancer cells in culture and inhibits xenograft growth in athym...
Caveolin1 regulates VEGFstimulated angiogenic activities in prostate cancer and endothelial cells
Immunohistochemical detection of tyrosine phosphatase SHP1 predicts outcome after radical prostatectomy for localized prostate cancer
Role of the protein tyrosine phosphatase SHP1 in Interleukin6 regulation of prostate cancer cells
Downregulation of 15lipoxygenase 2 by glucocorticoid receptor in prostate cancer cells
Gene therapy for prostate cancer
Effect of Ack1 tyrosine kinase inhibitor on ligandindependent androgen receptor activity
Gossypol induces apoptosis by activating p53 in prostate cancer cells and prostate tumorinitiating cells
Identification of EpCAM as a Molecular Target of Prostate Cancer Stroma
Anticancer activity of a cyclooxygenase inhibitor CX9051 in human prostate cancer cells the roles of NFkappaB and crosstalk between the extrinsic a...
Cryptocaryone a natural dihydrochalcone induces apoptosis in human androgen independent prostate cancer cells by death receptor clustering in lipi...
New prostate cancer data have been reported by MQ Chen and coauthors
New research on prostate cancer from University of California summarized
Growth inhibition of androgenresponsive prostate cancer cells with brefeldin A targeting cell cycle and androgen receptor
Resveratrol enhances p53 acetylation and apoptosis in prostate cancer by inhibiting MTA1NuRD complex
Downregulation of BiPGRP78 sensitizes resistant prostate cancer cells to genetherapeutic overexpression of REICDkk3
A phase II study of paclitaxel poliglumex in combination with transdermal estradiol for the treatment of metastatic castrationresistant prostate cancer ...
CCL2 is induced by chemotherapy and protects prostate cancer cells from docetaxelinduced cytotoxicity
ID1 enhances docetaxel cytotoxicity in prostate cancer cells through inhibition of p21
Downregulation of the nucleosomebinding protein 1 NSBP1 gene can inhibit the in vitro and in vivo proliferation of prostate cancer cells
14phenylenebismethyleneselenocyanate but not selenomethionine inhibits androgen receptor and Akt signaling in human prostate cancer cells
A variant of the KLK4 gene is expressed as a cis senseantisense chimeric transcript in prostate cancer cells
Research on prostate cancer detailed by scientists at Sydney Cancer Center
Researchers from Royal Marsden Hospital provide details of new studies and findings in the area of hormones
Researchers from University Hospital publish new studies and findings in the area of prostate cancer
Androgen receptormTOR crosstalk is regulated by testosterone availability implication for prostate cancer cell survival
PIM1 gene RNA interference induces growth inhibition and apoptosis of prostate cancer cells and suppresses tumor progression in vivo
Differential phosphoprotein levels and pathway analysis identify the transition mechanism of LNCaP cells into androgenindependent cells
Adenosine A3 receptor suppresses prostate cancer metastasis by inhibiting NADPH oxidase activity
Reduced expression of programmed cell death 5 protein in tissue of human prostate cancer
CD147EMMPRIN and CD44 are potential therapeutic targets for metastatic prostate cancer
Molecular pathways mediating the antiinflammatory effects of calcitriol implications for prostate cancer chemoprevention and treatment
Studies from FM Tumminello et al further understanding of prostate cancer
Study results from NV Narizhneva et al provide new insights into small interference RNAs sirnas
SlugSNAI2 regulates cell proliferation and invasiveness of metastatic prostate cancer cell lines
Clinical outcome of patients with docetaxelresistant hormonerefractory prostate cancer treated with secondline cyclophosphamidebased metronomic c...
Docetaxel loaded oleic acidcoated hydroxyapatite nanoparticles enhance the docetaxelinduced apoptosis through activation of caspase2 in androgen i...
Efficacy of abiraterone acetate in postdocetaxel castrationresistant prostate cancer
Activation of FOXO1 is critical for the anticancer effect of methylseleninic acid in prostate cancer cells
miRNA 26a EXPRESSION IN A NOVEL PANEL OF AFRICAN AMERICAN PROSTATE CANCER CELL LINES
Elevated NCOR1 disrupts PPARalphagamma signaling in prostate cancer and forms a targetable epigenetic lesion
Prostate cancer finasteride extends PSA doubling time during intermittent hormone therapy
Microarray analysis reveals potential target genes of NFkappaB2p52 in LNCaP prostate cancer cells
Chemoprevention of prostate cancer with lycopene in the TRAMP model
Genistein reverses hypermethylation and induces active histone modifications in tumor suppressor gene BCell translocation gene 3 in prostate cancer
The Mechanism of Action of Estrogen in CastrationResistant Prostate Cancer Clues From Hormone Levels
External beam radiotherapy for prostate cancer patients on anticoagulation therapy how significant is the bleeding toxicity?
Stable alterations of CD44 isoform expression in prostate cancer cells decrease invasion and growth and alter ligand binding and chemosensitivity
Biofunctionalization of electrospun PCLbased scaffolds with perlecan domain IV peptide to create a 3D pharmacokinetic cancer model
Inhibition of calciumindependent phospholipase A2 activates p38 MAPK signaling pathways during cytostasis in prostate cancer cells
Docetaxelresistant prostate cancer cells remain sensitive to StritylLcysteinemediated Eg5 inhibition
Targeting MMP9 uPAR and cathepsin B inhibits invasion migration and activates apoptosis in prostate cancer cells
Inhibiting TNFmediated signaling a novel therapeutic paradigm for androgen independent prostate cancer
ECE1 influences prostate cancer cell invasion via ET1mediated FAK phosphorylation and ET1independent mechanisms
STX140 and STX641 Cause Apoptosis via the Intrinsic Mitochondrial Pathway and Downregulate Survivin and XIAP Expression in Ovarian and Pro...
Prolonging hormone sensitivity in prostate cancer xenografts through dual inhibition of AR and mTOR
Cytoprotective mitochondrial chaperone TRAP1 as a novel molecular target in localized and metastatic prostate cancer
Runx2 association with progression of prostate cancer in patients mechanisms mediating bone osteolysis and osteoblastic metastatic lesions
Antitumor activity of hyaluronic acid synthesis inhibitor 4methylumbelliferone in prostate cancer cells
Chemosensitization of prostate cancer by modulating Bcl2 family proteins
Persistent P21Cip1 induction mediates G1 cell cycle arrest by methylseleninic acid in DU145 prostate cancer cells
UDPglucose dehydrogenase as a novel fieldspecific candidate biomarker of prostate cancer
Pregnane X receptor as a therapeutic target to inhibit androgen activity
Paxillin regulates androgen and epidermal growth factorinduced MAPK signaling and cell proliferation in prostate cancer cells
NKX31 potentiates TNFalphaCHXinduced apoptosis of prostate cancer cells through increasing caspase3 expression and its activity
Eightplex iTRAQ analysis of variant metastatic human prostate cancer cells identifies candidate biomarkers of progression An exploratory study
Effects of simvastatin acetylsalicylic acid and rosiglitazone on proliferation of normal and cancerous prostate epithelial cells at therapeutic concentrati...
Downregulation of Egr1 by siRNA inhibits growth of human prostate carcinoma cell line PC3
A modular Phase I study of lenalidomide and paclitaxel in metastatic castrationresistant prostate cancer following prior taxane therapy
Nanoparticlemediated thermal therapy Evolving strategies for prostate cancer therapy
FKBP51 and Cyp40 are positive regulators of androgendependent prostate cancer cell growth and the targets of FK506 and cyclosporin A
Rosuvastatin identified from a zebrafish chemical genetic screen for antiangiogenic compounds suppresses the growth of prostate cancer
Effectiveness pharmacokinetics and safety of a new sustainedrelease leuprolide acetate 375mg depot formulation for testosterone suppression in patie...
Estradiol suppresses tissue androgens and prostate cancer growth in castration resistant prostate cancer
Disruption of androgen and estrogen receptor activity in prostate cancer by a novel dietary diterpene carnosol implications for chemoprevention
Prostate cancer patients on androgen deprivation therapy develop persistent changes in adaptive immune responses
The role of docetaxel based therapy for prostate cancer in the era of targeted medicine
125dihydroxyvitamin D3 and PI3KAKT inhibitors synergistically inhibit growth and induce senescence in prostate cancer cells
Targeted photodynamic therapy for prostate cancer inducing apoptosis via activation of the caspase83 cascade pathway
Prostate cancer cell death produced by the codelivery of BclxL shRNA and doxorubicin using an aptamerconjugated polyplex